Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Bjpsych Open|June 15, 2022
Examining the long-term cognitive effects of exposure to the Canterbury earthquakes in a resilient cohortCaroline Bell, Will Moot, Richard Porter, et al.
American Journal of Psychotherapy|December 11, 2020
Patients' Perceptions of Functional Improvement in Psychotherapy for Mood DisordersMarie Crowe, Maree Inder, Richard Porter, et al.
Bjpsych Open|July 7, 2026
Applying cultural psychiatry to non-pharmacological interventionsKamaldeep Bhui, Richard Porter, Katie Douglas, et al.
The Australian and New Zealand Journal of Psychiatry|January 13, 2018
Patient predictors of response to cognitive behaviour therapy and schema therapy for depressionJanet D Carter, Virginia Vw McIntosh, Jennifer Jordan, et al.
American Journal of Psychotherapy|November 23, 2019
Interpersonal and Social Rhythm Therapy for Patients With Major Depressive DisorderMarie Crowe, Maree Inder, Katie Douglas, et al.
BMJ Open|July 4, 2025
Cognitive deficits in treatment-resistant depression: protocol for a systematic review and meta-analysisEivind Haga Ronold, Daniel Jensen, Anders Lillevik L Thorsen, et al.
BMJ Open|May 1, 2024
Protocol for a randomised controlled trial of ketamine versus ketamine and behavioural activation therapy for adults with treatment-resistant depression in the communityBen Beaglehole, Richard Porter, Katie Douglas, et al.
Longitudinal and Life Course Studies : International Journal|August 3, 2022
Recruitment and retention of participants in longitudinal studies after a natural disasterGeraldine F H McLeod, L John Horwood, Brian A Darlow, et al.
Bipolar Disorders|February 17, 2022
Randomised controlled cognition trials in remitted patients with mood disorders published between 2015 and 2021: A systematic review by the International Society for Bipolar Disorders Targeting Cognition Task ForceKamilla W Miskowiak, Ida Seeberg, Mette B Jensen, et al.
Bipolar Disorders|March 4, 2024
Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task ForceKamilla W Miskowiak, Zacharias K Obel, Riccardo Guglielmo, et al.
Pageof 3